Ananda Pharma

Ananda Pharma is an AQSE-listed UK biotechnology company developing pharmaceutical-grade cannabidiol formulations as licensed medicines for chronic inflammatory pain conditions.

The company focuses on essentially THC-free CBD products manufactured to UK pharmaceutical standards, targeting conditions including musculoskeletal pain where current treatments are inadequate.

Its pipeline is supported by clinical trial partnerships with academic researchers and informed by a substantial NICE evidence review into CBD for chronic pain.